Gallbladder disease Cholelithiasis and cholecystitis have been reported, consistent with rapid weight loss generally
Abstract Providing NO-system importance, we suggest that one single application of the NOS-blocker L-NAME may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application
Scientific World Journal 2006
For Libido Lift Rx and Drive For Her, they include: Both products (and O-Cream Rx) are unsafe for individuals who are pregnant or nursing
In obesity management, conventional interventions, such as lifestyle modification and traditional pharmacotherapy, demonstrate limited efficacy in patients with moderate to severe obesity, and sustained weight loss is difficult to achieve
Consume before, during, or after physical activity, or whenever additional hydration is needed